LOADING

Type to search

Author: Frank Vinluan

bcma-delay:-fda-refuses-review-of-bristol-drug,-asks-for-more-info
pliant-pushes-forward-with-ipo-plans-to-back-fibrosis-drug-studies
celsius-therapeutics-names-jeanne-magram-chief-scientific-officer
bolt-bio-picks-sunesis’s-william-quinn-as-chief-financial-officer
myokardia’s-heart-drug-shines-in-phase-3,-fda-filing-planned-for-2021
eli-lilly-gets-edge-in-the-“ret”-race-with-fda-nod-for-cancer-drug
bio-roundup:-acquisitive-alexion,-crispr-on-covid,-c.-diff-success-&-more
ayala’s-ipo-raises-$55m-to-test-two-former-bristol-myers-cancer-drugs
gemini-therapeutics-names-ex-achillion-exec-marc-uknis-chief-medical-officer
novartis-drug-wins-fda-approval-for-lung-cancers-with-specific-mutation